Through ongoing conversations with healthcare providers and patients, we identified an emerging global health challenge: multiple chronic conditions (MCC). 

MCCs are characterized by the presence of two or more chronic conditions. These chronic conditions are mostly non-communicable, such as cardiovascular diseases, but they do include some communicable diseases, such as tuberculosis and human immunodeficiency virus.

The growing burden of managing multiple chronic conditions (MCC) magnifies the complexity of treatment, exponentially increases healthcare costs and, most importantly, affects individuals, caregivers, communities, and health systems1.

Through multisectoral partnerships, Teva is committed to helping address MCC by supporting design and implementation of evidence-based care programs targeting concrete outcomes. Working together, we have the potential to improve quality of life for people with MCC and their caregivers, while also decreasing health costs to individuals and society.

______________________________________


1 Multiple Chronic Conditions: The Global State, https://www.tevapharm.com/files/docs/Teva_MCC_Report.pdf